SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 102 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $11,330,000 | – | 540,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 135,400 | $3,164,000 | 1.68% |
| First Light Asset Management, LLC | 64,856 | $1,516,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 1,038,504 | $24,270,000 | 1.00% |
| Tekla Capital Management LLC | 404,731 | $9,459,000 | 0.95% |
| Broadfin Capital, LLC | 380,188 | $8,885,000 | 0.86% |
| Perimeter Capital Partners, LLC | 73,342 | $1,714,000 | 0.85% |
| Penn Capital Management Company, LLC | 676,111 | $15,801,000 | 0.60% |
| B. Riley Wealth Advisors, Inc. | 28,217 | $659,000 | 0.20% |
| NWQ INVESTMENT MANAGEMENT COMPANY, LLC | 855,750 | $19,999,000 | 0.18% |
| SECOR Capital Advisors, LP | 12,522 | $293,000 | 0.14% |